常见的AML遗传突变与免疫环境之间的相互作用:免疫反应的机制和影响
Xuege Guo1, Hanlu Zhang1, Xiao Wang1
1Department of Hematology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Frontiers in immunology
|August 27, 2025
概括
这篇评论探讨了急性髓性白血病 (AML) 的基因突变如何影响免疫系统. 了解这些遗传驱动因素是开发AML新免疫疗法的关键.
科学领域:
- 血液学
- 免疫学
- 癌症学
背景情况:
- 急性髓性白血病 (AML) 是一种复杂的血液癌症,具有多种遗传突变.
- 特定突变影响瘤进展和AML的免疫逃避.
- 需要进一步阐明AML遗传与免疫微环境之间的相互作用.
研究的目的:
- 审查常见的AML突变的免疫后果.
- 探索AML风险群体之间的免疫反应转移.
- 突出针对突变衍生新皮质的免疫疗法潜力.
主要方法:
- 对常见的AML突变进行文献综述 (例如FLT3-ITD,NPM1,DNMT3A,TP53,IDH1/2,NRAS).
- 在AML微环境中分析免疫细胞透和失调.
- 检查与遗传变异相关的免疫激活和抑制动态.
主要成果:
- 常见的AML突变显著重塑免疫微环境.
- 基因变化影响免疫激活与抑制的平衡.
- 特定突变与AML的独特免疫特征相关.
结论:
- 整合遗传和免疫学见解对于AML治疗至关重要.
- 针对驱动突变的新皮质提供了一个有前途的免疫治疗策略.
- 开发精确的免疫疗法可以克服AML的免疫逃逸.
相关概念视频
Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


